|
|
Volumn 2, Issue 3, 2005, Pages 132-133
|
|
Can serum markers be used to reliably detect liver fibrosis?
|
|
Author keywords
Immunoassays; Liver biopsy; Liver fibrosis; Serum markers
|
|
Indexed keywords
BIOLOGICAL MARKER;
HYALURONIC ACID;
PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE;
TISSUE INHIBITOR OF METALLOPROTEINASE 1;
ALGORITHM;
BLOOD ANALYSIS;
BLOOD SAMPLING;
CHRONIC LIVER DISEASE;
CLINICAL TRIAL;
DIAGNOSTIC PROCEDURE;
DISEASE SEVERITY;
HUMAN;
INTERMETHOD COMPARISON;
LIVER BIOPSY;
LIVER CELL CARCINOMA;
LIVER FIBROSIS;
LIVER FUNCTION TEST;
MULTICENTER STUDY;
NON INVASIVE MEASUREMENT;
PATIENT SELECTION;
PREDICTION;
PRIORITY JOURNAL;
RELIABILITY;
SAFETY;
SENSITIVITY AND SPECIFICITY;
SHORT SURVEY;
VALIDATION PROCESS;
BIOLOGICAL MARKERS;
BIOPSY;
COLLAGEN TYPE III;
DISEASE PROGRESSION;
HUMANS;
HYALURONIC ACID;
LIVER CIRRHOSIS;
SENSITIVITY AND SPECIFICITY;
SEVERITY OF ILLNESS INDEX;
TISSUE INHIBITOR OF METALLOPROTEINASE-1;
|
|
EID: 20444493582
PISSN: 17434378
EISSN: None
Source Type: Journal
DOI: 10.1038/ncpgasthep0120 Document Type: Short Survey |
|
Times cited : (7)
|
|
References (4)
|
